EUDA Health Holdings Limited (EUDA) Income Statement
EUDA 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsEUDA revenue and net income
Where EUDA's revenue goes
2025Each bar shows an amount and its share of revenue. EUDA kept −40.7% of revenue as net income.
EUDA profit margins
EUDA growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | +70.0% | +21.9% | −5.1% | — |
| Gross profit | +292.7% | +51.0% | −5.1% | — |
| Operating income | — | — | — | — |
| Net income | — | — | — | — |
| EPS (diluted) | — | — | — | — |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
EUDA quarterly EPS vs estimates
EUDA Health beat the analyst EPS estimate in 1 of the last 5 quarters.
EUDA income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Revenue | $6.8M | $4.0M | $3.7M | $3.8M | $4.6M | $8.9M |
| Cost of revenue | $3.8M | $3.2M | $2.9M | $2.9M | $3.3M | $5.0M |
| Gross profit | $3.0M | $762,155 | $842,075 | $869,999 | $1.2M | $3.9M |
| Research & development | $249 | $0 | $0 | $17,209 | $129,265 | $158,011 |
| Sales, general & admin | $5.4M | $3.3M | $4.8M | $6.8M | $1.5M | $4.6M |
| Total operating expenses | $5.4M | $18.1M | $4.8M | $13.1M | $1.8M | $4.8M |
| Operating income | −$2.4M | −$17.3M | −$4.0M | −$5.7M | −$559,993 | −$893,556 |
| Interest expense | $228,624 | $44,890 | $23,225 | $93,782 | $127,126 | $65,819 |
| Income before taxes | −$2.7M | −$17.6M | −$8.4M | −$24.9M | $1.7M | $246,449 |
| Income taxes | $41,935 | −$4,379 | $1.6M | −$20,789 | $46,488 | $47,477 |
| Net income | −$2.8M | −$15.4M | −$10.0M | −$24.9M | $864,829 | $175,575 |
| EBITDA | −$2.1M | −$17.4M | −$8.3M | −$24.6M | $1.3M | −$669,440 |
| EPS (diluted) | −$1.47 | −$8.27 | −$9.10 | −$0.56 | −$0.03 | — |
| Gross margin | 43.9% | 19.0% | 22.7% | 23.1% | 27.4% | 43.8% |
| Operating margin | −35.8% | −432.2% | −106.9% | −151.9% | −12.3% | −10.1% |
| Net margin | −40.7% | −382.9% | −270.9% | −661.1% | 19.0% | 2.0% |
| Jun '26 | Mar '26 | Sep '25 | Mar '25 | Sep '24 | Mar '24 | Jun '23 | Mar '23 | Dec '22 | Sep '22 | Jun '22 | Mar '22 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.7M | $1.7M | $1.9M | $1.5M | $1.1M | $954,024 | $1.1M | $2.4M | $2.4M | $2.3M | $2.4M | $2.7M |
| Cost of revenue | $1.1M | $1.1M | $802,728 | $1.1M | $891,437 | $732,988 | $809,081 | $1.6M | $1.6M | $1.7M | $1.8M | $1.4M |
| Gross profit | $640,943 | $640,943 | $1.1M | $417,657 | $160,042 | $221,036 | $298,005 | $817,627 | $817,627 | $604,681 | $660,642 | $1.3M |
| Research & development | $637 | $637 | $3 | $122 | — | — | $16,616 | $2,145 | $2,145 | $4,923 | $7,195 | $2,946 |
| Sales, general & admin | $985,042 | $985,042 | $1.7M | $983,624 | $655,097 | $1.0M | $2.2M | $4.1M | $3.3M | $958,458 | $2.4M | $824,896 |
| Total operating expenses | $1.0M | $1.0M | $1.8M | $983,746 | $655,098 | $8.4M | $2.4M | $23.4M | −$23.4M | $1.3M | $2.4M | $481,638 |
| Operating income | −$380,769 | −$380,769 | −$672,907 | −$566,089 | −$495,056 | −$8.2M | −$2.1M | −$9.7M | −$8.5M | −$298,330 | −$1.2M | $75,312 |
| Interest expense | — | $228,624 | $92,483 | $21,829 | $964 | $21,481 | $7,382 | $84,160 | $84,160 | $22,464 | $11,999 | $20,087 |
| Income before taxes | −$426,208 | −$426,208 | −$759,903 | −$602,985 | −$446,454 | −$8.4M | −$6.1M | −$22.6M | −$22.6M | $201,012 | −$1.8M | −$472,989 |
| Income taxes | $27,733 | $27,733 | $23,105 | $2,137 | $1,700 | −$490 | −$123 | −$57,103 | $57,103 | −$23,428 | $92,130 | $5,823 |
| Net income | −$397,502 | −$397,502 | −$784,380 | −$602,000 | $735,337 | −$8.4M | −$6.1M | −$22.5M | −$22.5M | $201,012 | −$1.9M | −$472,989 |
| EBITDA | −$322,419 | −$322,419 | −$540,150 | −$476,868 | −$476,939 | −$788,976 | −$6.1M | −$8.5M | −$8.5M | −$695,547 | −$1.7M | $129,360 |
| EPS (diluted) | — | — | −$0.03 | −$0.02 | −$0.59 | — | −$5.67 | −$2.39 | — | $0.02 | −$0.09 | −$0.04 |
| Gross margin | 37.0% | 37.0% | 57.3% | 27.3% | 15.2% | 23.2% | 26.9% | 33.6% | 33.6% | 26.2% | 27.2% | 47.7% |
| Operating margin | −22.0% | −22.0% | −35.8% | −37.0% | −47.1% | −856.6% | −185.9% | −397.3% | −350.5% | −12.9% | −50.8% | 2.8% |
| Net margin | −22.9% | −22.9% | −41.7% | −39.4% | 69.9% | −881.9% | −551.0% | −924.5% | −924.5% | 8.7% | −76.6% | −17.7% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in EUDA's financial statements (latest annual report filed April 28, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
EUDA financial results
In fiscal year 2025 (ended December 31, 2025), EUDA Health reported revenue of $6.8 million, up 70.0% from the year before. It had a net loss of $2.8 million, a net profit margin of −40.7%. Diluted earnings per share came to −$1.47. Over five years revenue grew at an average rate of −5.1% a year.
See the EUDA stock overview for the latest quote and news, or the EUDA chart for price history and technical indicators.
EUDA income statement FAQ
What is EUDA Health's annual revenue?
EUDA Health reported total revenue of $6.8 million for fiscal year 2025, which ended on December 31, 2025. That was up 70.0% from $4.0 million the previous year.
Is EUDA Health profitable?
No. EUDA Health reported a net loss of $2.8 million in fiscal 2025, a net profit margin of −40.7%; its operating margin was −35.8%.
What is EUDA Health's gross margin?
EUDA Health's gross margin was 43.9% in fiscal 2025: for every $100 of revenue, EUDA Health kept $44 after the direct cost of its products and services.
How much does EUDA Health spend on research and development?
EUDA Health spent $0.0 million on research and development in fiscal 2025, 0.0% of revenue.
How fast is EUDA Health growing?
Revenue grew −5.1% a year on average over the last five fiscal years, from $8.9 million to $6.8 million.
What are EUDA Health's earnings per share?
EUDA Health earned $-1.47 per diluted share in fiscal 2025, compared with $-8.27 a year earlier.
When does EUDA Health's fiscal year end?
EUDA Health's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on April 28, 2026.